Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Iron, Hepcidin, and Death in Human AKI.

Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, Eisenga MF, Singh K, Babitt JL, Kellum JA, Palevsky PM, Christov M, Waikar SS.

J Am Soc Nephrol. 2019 Feb 8. pii: ASN.2018100979. doi: 10.1681/ASN.2018100979. [Epub ahead of print]

PMID:
30737269
2.

Serum Metabolomic Alterations Associated with Proteinuria in CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Appel LJ, Chen J, Vasan RS, Anderson AH, Feldman HI, Kimmel PL, Waikar SS, Köttgen A, Evans AM, Levey AS, Inker LA, Sarnak MJ, Grams ME; Chronic Kidney Disease Biomarkers Consortium Investigators.

Clin J Am Soc Nephrol. 2019 Feb 7. pii: CJN.10010818. doi: 10.2215/CJN.10010818. [Epub ahead of print]

PMID:
30733224
3.

When to stop renal replacement therapy in anticipation of renal recovery in AKI: The need for consensus guidelines.

Kelly YP, Waikar SS, Mendu ML.

Semin Dial. 2019 Jan 28. doi: 10.1111/sdi.12773. [Epub ahead of print]

PMID:
30690779
4.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.

PMID:
30635225
5.

Erratum.

Palsson R, Chandraker AK, Curhan GC, Rennke HG, McMahon GM, Waikar SS.

Nephrol Dial Transplant. 2018 Dec 22. doi: 10.1093/ndt/gfy364. [Epub ahead of print] No abstract available.

PMID:
30590582
6.

Variability of Two Metabolomic Platforms in CKD.

Rhee EP, Waikar SS, Rebholz CM, Zheng Z, Perichon R, Clish CB, Evans AM, Avila J, Denburg MR, Anderson AH, Vasan RS, Feldman HI, Kimmel PL, Coresh J; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):40-48. doi: 10.2215/CJN.07070618. Epub 2018 Dec 20.

PMID:
30573658
7.

Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease.

Han Z, Xiao Z, Kalantar-Zadeh K, Moradi H, Shafi T, Waikar SS, Quarles LD, Yu Z, Tin A, Coresh J, Kovesdy CP.

Diagnostics (Basel). 2018 Oct 8;8(4). pii: E71. doi: 10.3390/diagnostics8040071.

8.

The association of calcium oxalate deposition in kidney allografts with graft and patient survival.

Palsson R, Chandraker AK, Curhan GC, Rennke HG, McMahon GM, Waikar SS.

Nephrol Dial Transplant. 2018 Aug 27. doi: 10.1093/ndt/gfy271. [Epub ahead of print]

PMID:
30165691
9.

De novo NAD+ biosynthetic impairment in acute kidney injury in humans.

Poyan Mehr A, Tran MT, Ralto KM, Leaf DE, Washco V, Messmer J, Lerner A, Kher A, Kim SH, Khoury CC, Herzig SJ, Trovato ME, Simon-Tillaux N, Lynch MR, Thadhani RI, Clish CB, Khabbaz KR, Rhee EP, Waikar SS, Berg AH, Parikh SM.

Nat Med. 2018 Sep;24(9):1351-1359. doi: 10.1038/s41591-018-0138-z. Epub 2018 Aug 20.

PMID:
30127395
10.

Biological Variability of Estimated GFR and Albuminuria in CKD.

Waikar SS, Rebholz CM, Zheng Z, Hurwitz S, Hsu CY, Feldman HI, Xie D, Liu KD, Mifflin TE, Eckfeldt JH, Kimmel PL, Vasan RS, Bonventre JV, Inker LA, Coresh J; Chronic Kidney Disease Biomarkers Consortium Investigators.

Am J Kidney Dis. 2018 Oct;72(4):538-546. doi: 10.1053/j.ajkd.2018.04.023. Epub 2018 Jul 18.

PMID:
30031564
11.

The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.

Srivastava A, Palsson R, Kaze AD, Chen ME, Palacios P, Sabbisetti V, Betensky RA, Steinman TI, Thadhani RI, McMahon GM, Stillman IE, Rennke HG, Waikar SS.

J Am Soc Nephrol. 2018 Aug;29(8):2213-2224. doi: 10.1681/ASN.2017121260. Epub 2018 Jun 4.

PMID:
29866798
12.

Renal Functional Reserve Revisited.

Palsson R, Waikar SS.

Adv Chronic Kidney Dis. 2018 May;25(3):e1-e8. doi: 10.1053/j.ackd.2018.03.001. Review.

PMID:
29793670
13.

Association of Albuminuria With Major Adverse Outcomes in Adults With Congenital Heart Disease: Results From the Boston Adult Congenital Heart Biobank.

Rajpal S, Alshawabkeh L, Almaddah N, Joyce CM, Shafer K, Gurvitz M, Waikar SS, Mc Causland FR, Landzberg MJ, Opotowsky AR.

JAMA Cardiol. 2018 Apr 1;3(4):308-316. doi: 10.1001/jamacardio.2018.0125.

PMID:
29541749
14.

Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.

Leaf DE, Siew ED, Eisenga MF, Singh K, Mc Causland FR, Srivastava A, Ikizler TA, Ware LB, Ginde AA, Kellum JA, Palevsky PM, Wolf M, Waikar SS.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):531-541. doi: 10.2215/CJN.10810917. Epub 2018 Mar 8.

PMID:
29519954
15.

Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin.

Motwani SS, McMahon GM, Humphreys BD, Partridge AH, Waikar SS, Curhan GC.

J Clin Oncol. 2018 Mar 1;36(7):682-688. doi: 10.1200/JCO.2017.75.7161. Epub 2018 Jan 10.

16.

Expanding the Role for Kidney Biopsies in Acute Kidney Injury.

Waikar SS, McMahon GM.

Semin Nephrol. 2018 Jan;38(1):12-20. doi: 10.1016/j.semnephrol.2017.09.001. Review.

17.

Non-tunneled versus tunneled dialysis catheters for acute kidney injury requiring renal replacement therapy: a prospective cohort study.

Mendu ML, May MF, Kaze AD, Graham DA, Cui S, Chen ME, Shin N, Aizer AA, Waikar SS.

BMC Nephrol. 2017 Dec 4;18(1):351. doi: 10.1186/s12882-017-0760-x.

18.

Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.

Srivastava A, Kaze AD, McMullan CJ, Isakova T, Waikar SS.

Am J Kidney Dis. 2018 Mar;71(3):362-370. doi: 10.1053/j.ajkd.2017.08.017. Epub 2017 Nov 11.

PMID:
29132945
19.

Acute blood loss stimulates fibroblast growth factor 23 production.

Rabadi S, Udo I, Leaf DE, Waikar SS, Christov M.

Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F132-F139. doi: 10.1152/ajprenal.00081.2017. Epub 2017 Sep 6.

20.

BPI Fold-Containing Family A Member 2/Parotid Secretory Protein Is an Early Biomarker of AKI.

Kota SK, Pernicone E, Leaf DE, Stillman IE, Waikar SS, Kota SB.

J Am Soc Nephrol. 2017 Dec;28(12):3473-3478. doi: 10.1681/ASN.2016121265. Epub 2017 Aug 3.

21.

Evaluating the feasibility of the KDIGO CKD referral recommendations.

Singh K, Waikar SS, Samal L.

BMC Nephrol. 2017 Jul 7;18(1):223. doi: 10.1186/s12882-017-0646-y.

22.

Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.

Cardenas-Gonzalez M, Srivastava A, Pavkovic M, Bijol V, Rennke HG, Stillman IE, Zhang X, Parikh S, Rovin BH, Afkarian M, de Boer IH, Himmelfarb J, Waikar SS, Vaidya VS.

Clin Chem. 2017 Sep;63(9):1515-1526. doi: 10.1373/clinchem.2017.274175. Epub 2017 Jun 30.

23.

Intradialytic hypotension in acute kidney injury requiring renal replacement therapy.

Sharma S, Waikar SS.

Semin Dial. 2017 Nov;30(6):553-558. doi: 10.1111/sdi.12630. Epub 2017 Jun 30.

PMID:
28666082
24.

Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation.

Gerarduzzi C, Kumar RK, Trivedi P, Ajay AK, Iyer A, Boswell S, Hutchinson JN, Waikar SS, Vaidya VS.

JCI Insight. 2017 Apr 20;2(8). pii: 90299. doi: 10.1172/jci.insight.90299. [Epub ahead of print]

25.

Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise.

Birmingham DJ, Merchant M, Waikar SS, Nagaraja H, Klein JB, Rovin BH.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i71-i79. doi: 10.1093/ndt/gfw300. Review.

26.

Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.

Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, Mifflin T, Waikar SS, Sabbisetti VS, Bonventre JV, Coresh J, Nelson RG, Kimmel PL, Kusek JW, Rahman M, Schelling JR, Vasan RS, Liu KD; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2017 May 8;12(5):761-771. doi: 10.2215/CJN.08560816. Epub 2017 Mar 2.

27.

Biomarker validation with an imperfect reference: Issues and bounds.

Emerson SC, Waikar SS, Fuentes C, Bonventre JV, Betensky RA.

Stat Methods Med Res. 2018 Oct;27(10):2933-2945. doi: 10.1177/0962280216689806. Epub 2017 Feb 6.

PMID:
28166709
28.

Kidney Disease Population Health Management in the Era of Accountable Care: A Conceptual Framework for Optimizing Care Across the CKD Spectrum.

Mendu ML, Waikar SS, Rao SK.

Am J Kidney Dis. 2017 Jul;70(1):122-131. doi: 10.1053/j.ajkd.2016.11.013. Epub 2017 Jan 26.

PMID:
28132720
29.

A Decision-Making Algorithm for Initiation and Discontinuation of RRT in Severe AKI.

Mendu ML, Ciociolo GR Jr, McLaughlin SR, Graham DA, Ghazinouri R, Parmar S, Grossier A, Rosen R, Laskowski KR, Riella LV, Robinson ES, Charytan DM, Bonventre JV, Greenberg JO, Waikar SS.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):228-236. doi: 10.2215/CJN.07170716. Epub 2017 Jan 24.

30.

Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.

Hsu CY, Xie D, Waikar SS, Bonventre JV, Zhang X, Sabbisetti V, Mifflin TE, Coresh J, Diamantidis CJ, He J, Lora CM, Miller ER, Nelson RG, Ojo AO, Rahman M, Schelling JR, Wilson FP, Kimmel PL, Feldman HI, Vasan RS, Liu KD; CRIC Study Investigators; CKD Biomarkers Consortium.

Kidney Int. 2017 Jan;91(1):196-203. doi: 10.1016/j.kint.2016.09.003. Epub 2016 Oct 28.

31.

Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.

Leaf DE, Jacob KA, Srivastava A, Chen ME, Christov M, Jüppner H, Sabbisetti VS, Martin A, Wolf M, Waikar SS.

J Am Soc Nephrol. 2017 Jun;28(6):1877-1885. doi: 10.1681/ASN.2016080836. Epub 2016 Dec 27.

32.

A Concept-Wide Association Study of Clinical Notes to Discover New Predictors of Kidney Failure.

Singh K, Betensky RA, Wright A, Curhan GC, Bates DW, Waikar SS.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2150-2158. Epub 2016 Oct 10.

33.

Length Polymorphisms in Heme Oxygenase-1 and AKI after Cardiac Surgery.

Leaf DE, Body SC, Muehlschlegel JD, McMahon GM, Lichtner P, Collard CD, Shernan SK, Fox AA, Waikar SS.

J Am Soc Nephrol. 2016 Nov;27(11):3291-3297. Epub 2016 Jun 2.

34.

Electronic Consultations in Nephrology: Pilot Implementation and Evaluation.

Mendu ML, McMahon GM, Licurse A, Solomon S, Greenberg J, Waikar SS.

Am J Kidney Dis. 2016 Nov;68(5):821-823. doi: 10.1053/j.ajkd.2016.05.029. Epub 2016 Aug 5. No abstract available.

PMID:
27503182
35.

Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks.

Pang P, Abbott M, Chang SL, Abdi M, Chauhan N, Mistri M, Ghofrani J, Fucci QA, Walker C, Leonardi C, Grady S, Halim A, Hoffman R, Lu T, Cao H, Tullius SG, Malek S, Kumar S, Steele G, Kibel A, Freedman BS, Waikar SS, Siedlecki AM.

Kidney Int. 2017 Jan;91(1):129-143. doi: 10.1016/j.kint.2016.07.037. Epub 2016 Sep 29.

36.

Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.

Opotowsky AR, Baraona FR, Mc Causland FR, Loukas B, Landzberg E, Landzberg MJ, Sabbisetti V, Waikar SS.

Heart. 2017 Mar;103(6):434-442. doi: 10.1136/heartjnl-2016-309729. Epub 2016 Sep 26.

37.

ADAM17 substrate release in proximal tubule drives kidney fibrosis.

Kefaloyianni E, Muthu ML, Kaeppler J, Sun X, Sabbisetti V, Chalaris A, Rose-John S, Wong E, Sagi I, Waikar SS, Rennke H, Humphreys BD, Bonventre JV, Herrlich A.

JCI Insight. 2016 Aug 18;1(13). pii: e87023.

38.

End Points for Clinical Trials in Acute Kidney Injury.

Leaf DE, Waikar SS.

Am J Kidney Dis. 2017 Jan;69(1):108-116. doi: 10.1053/j.ajkd.2016.05.033. Epub 2016 Sep 3.

39.

A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury.

Zhao B, Lu Q, Cheng Y, Belcher JM, Siew ED, Leaf DE, Body SC, Fox AA, Waikar SS, Collard CD, Thiessen-Philbrook H, Ikizler TA, Ware LB, Edelstein CL, Garg AX, Choi M, Schaub JA, Zhao H, Lifton RP, Parikh CR; TRIBE-AKI Consortium * .

Am J Respir Crit Care Med. 2017 Feb 15;195(4):482-490. doi: 10.1164/rccm.201603-0518OC.

40.

Needle Size and the Risk of Kidney Biopsy Bleeding Complications.

Cui S, Heller HT, Waikar SS, McMahon GM.

Kidney Int Rep. 2016 Aug 30;1(4):324-326. doi: 10.1016/j.ekir.2016.08.017. eCollection 2016 Nov. No abstract available.

41.

Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study.

Mc Causland FR, Asafu-Adjei J, Betensky RA, Palevsky PM, Waikar SS.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1335-42. doi: 10.2215/CJN.10991015. Epub 2016 Jul 22.

42.

Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.

Waikar SS, Sabbisetti V, Ärnlöv J, Carlsson AC, Coresh J, Feldman HI, Foster MC, Fufaa GD, Helmersson-Karlqvist J, Hsu CY, Kimmel PL, Larsson A, Liu Y, Lind L, Liu KD, Mifflin TE, Nelson RG, Risérus U, Vasan RS, Xie D, Zhang X, Bonventre JV; Chronic Kidney Disease Biomarkers Consortium Investigators.

Nephrol Dial Transplant. 2016 Sep;31(9):1460-70. doi: 10.1093/ndt/gfw203. Epub 2016 Jun 7.

43.

Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423.

Pavkovic M, Robinson-Cohen C, Chua AS, Nicoara O, Cárdenas-González M, Bijol V, Ramachandran K, Hampson L, Pirmohamed M, Antoine DJ, Frendl G, Himmelfarb J, Waikar SS, Vaidya VS.

Toxicol Sci. 2016 Jul;152(1):205-13. doi: 10.1093/toxsci/kfw077. Epub 2016 Apr 27.

44.

Introduction: The Past, Present, and Future of AKI Therapeutics.

Waikar SS.

Semin Nephrol. 2016 Jan;36(1):7. doi: 10.1016/j.semnephrol.2016.01.007. No abstract available.

PMID:
27085730
45.

Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.

Leaf DE, Christov M, Jüppner H, Siew E, Ikizler TA, Bian A, Chen G, Sabbisetti VS, Bonventre JV, Cai X, Wolf M, Waikar SS.

Kidney Int. 2016 Apr;89(4):939-48. doi: 10.1016/j.kint.2015.12.035. Epub 2016 Feb 17.

46.

Excessive diagnostic testing in acute kidney injury.

Leaf DE, Srivastava A, Zeng X, McMahon GM, Croy HE, Mendu ML, Kachalia A, Waikar SS.

BMC Nephrol. 2016 Jan 15;17:9. doi: 10.1186/s12882-016-0224-8.

47.

Clinical predictors of diagnostic testing utility in the initial evaluation of chronic kidney disease.

Mendu ML, Lundquist A, Aizer AA, Leaf DE, Robinson E, Steele DJ, Waikar SS.

Nephrology (Carlton). 2016 Oct;21(10):851-9. doi: 10.1111/nep.12676.

48.

Electronic Health Record Patient Portals in CKD and Hypertension Management: Meaningfully Used?

Mendu ML, Waikar SS.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1897-9. doi: 10.2215/CJN.10070915. Epub 2015 Oct 22. No abstract available.

49.

Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.

Samal L, Wright A, Waikar SS, Linder JA.

BMC Nephrol. 2015 Oct 12;16:162. doi: 10.1186/s12882-015-0154-x.

50.

RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis.

Craciun FL, Bijol V, Ajay AK, Rao P, Kumar RK, Hutchinson J, Hofmann O, Joshi N, Luyendyk JP, Kusebauch U, Moss CL, Srivastava A, Himmelfarb J, Waikar SS, Moritz RL, Vaidya VS.

J Am Soc Nephrol. 2016 Jun;27(6):1702-13. doi: 10.1681/ASN.2015020225. Epub 2015 Oct 8.

Supplemental Content

Loading ...
Support Center